Navigation Links
China's Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
Date:6/24/2008

HONG KONG, June 25 /Xinhua-PRNewswire-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Stock Code: 8180.HK) today is pleased to announce its annual results for the financial year ended 31 March 2008. Driven by remarkable organic growth of core businesses and exceptional gains from strategic investments, the Group reported record profit (after-tax) of HK$713,653,000, a jump of 209% over last year. The Group's basic earnings per share increased by 198% to HK44.1 cents.

Turnover of the core businesses rose to HK$421,147,000, representing a rise of 27%. The realized gains from the strategic investments contributed HK$332,435,000 to the Group's profit, up 355% over last year. The Group's net asset value rose to HK$3,553,964,000 at a compound annual growth rate (CAGR) exceeding 47% over the last five years.

Mr. Kam Yuen, Chairman of Golden Meditech said, "We position ourselves as a high-growth, integrated hi-tech medical device and healthcare services enterprise. Golden Meditech is not only the largest blood related medical device manufacturer in China, but also the first and largest umbilical cord blood bank service provider in China. Golden Meditech has also had significant interest in one of the largest natural herbal healthcare chains in England and Ireland -- China Healthcare Inc. (CHI). We intend to maintain a leading dominant position in each of individual business segments."

Among the Group's three core business segments, the Medical Device Segment remained the principle source of the revenue, accounting for 67% of total revenue last year. However, the revenue contribution from the Cord Blood Bank Segment has been steadily rising after consecutive years of high growth, and its share has now rose from last year's 19% to 33% this year. The Medical Device Segment is expected to bring in stable and substantial revenue to the Group whereas the revenue of the Cord Blood Bank Segment will be rapidly increasing.

Golden Meditech's proactive and prudent strategic investments and acquisitions in the past had paid off. One excellent example about our strategic investments was the acquisition of cord blood bank business in 2003. Since the acquisition, the cord blood bank business's newly subscribers had exceeded 100% (CAGR). The Group, had also during the year, successfully brought in new strategic investor in its personal electronic consumer goods sales channel, raising a total of US$90 million at the valuation at 50% above the Group's initial cost. Golden Meditech now owns 37.8% UCMC, the largest medical equipment distributor in China and 33.5% Pypo Digital, a nationwide consumer electronic products distributor.

About Golden Meditech Company Limited

Golden Meditech: Founded in 2000 and listed on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited in December 2001, Golden Meditech is the first hi-tech medical device enterprise that went public outside of the PRC. During the past few years, thanks to its great efforts in innovation and market expansion, as well as its first-mover abilities in capturing the emerging market opportunities, Golden Meditech's medical device, healthcare services and natural herbal medicines have all established dominant positions in each of its own sectors. Going forward, Golden Meditech will continue its pursuit of becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.

For enquiries, please contact the investor relations department of Golden Meditech Company Limited.

Contact:

Dennis Haikuan Lu

Investor Relations Manager

Golden Meditech Company Limited (8180.HK)

Tel: +852-3605-8138

Fax: +852-3605-8181

Email: ir@goldenmeditech.com


'/>"/>
SOURCE Golden Meditech Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
4. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
5. Leading-edge body sensor could help produce sporting champions
6. Hospital Quality Info on Web Can Be Misleading
7. AT&T Establishes New Network Services for Leading Medical Liability Insurer
8. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
9. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
10. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
11. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... UK (PRWEB) , ... May 06, 2016 , ... ... success in changing the way the pharmaceutical industry conducts clinical trials. This month Ibs ... most influential people in pharma, and he was honored as a Tech Disruptor by ...
(Date:5/6/2016)... ... May 06, 2016 , ... US Sports Camps has ... camp held at Oregon State University this summer. Employing world-class rugby figures, including former ... all skill levels with training on key fundamentals, match play, fitness and more. , ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... feature AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery Channel. ... vision of becoming a leader in optimized drug discovery through innovative cellular analysis. ...
(Date:5/6/2016)... ... May 06, 2016 , ... Online HR/benefits platforms offer a range of ... for traditional brokers and health plans. “ The Rapid Emergence of Online Benefits Firms: ... Information Services, Inc. (AIS), will offer an accurate picture of online benefits today, and ...
(Date:5/6/2016)... ... ... Canadian author Mark Black is a speaker, author, and life strategy coach who ... … with the help of his publisher Strategic Book Group and its subsidiary Publish ... bed waiting for a miracle: He needed a heart and double-lung transplant. From this came ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... Research and Markets has ... Keratosis Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Actinic ... Keratosis market valuations and forecast, Actinic Keratosis ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
Breaking Medicine Technology: